Other languages Mayne Pharma Group Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:42 02/05/2024 am IST			5-day change	1st Jan Change
7.01 ^AUD	+3.09%		-1.54%	+13.98%

26/02	Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	MT
25/02	Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024

Lagere omzet Mithra ondanks hogere productomzet	08/03
Mithra zet zichzelf in de etalage	05/03
Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	26/02
Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
Brussel schudt tegenvallende inflatie data van zich af	17/02
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	16/02
Brussel sluit in het groen	15/02
Chemie en zorgvastgoed trekken de kop	15/02
Kleine winsten in Brussel	15/02
Brusselse beurs opent in het groen	15/02
Mithra verkoopt Mayne Pharma	15/02
An undisclosed buyer acquired a 5.06% stake in Mayne Pharma Group Limited from Mithra Pharmaceuticals SA for AUD 21 million	15/02
Mayne Pharma Group Limited Approves Election of Anne Lockwood	30/11
Mithra Pharmaceuticals Obtains US Patent for Contraceptive Pill	07/11
Aanvullend Amerikaans patent voor Mithra	07/11
Mayne Pharma Gets Additional US Patent for Contraceptive	06/11
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor	03/11
Mayne Pharma Acquires Dermatological Medication	26/23/26
Mayne Pharma Group Limited completed the acquisition of Assets Related To RHOFADE® (Oxymetazoline Hydrochloride) Cream 1% from EPI Health, LLC.	25/23/25
Mithra focust op Estelle en Donesta	11/23/11

No results for this search